This website is intended for healthcare professionals only

Educational Resources
This section includes resources developed by Guidelines and Guidelines in Practice. Checklists, formulary decision guides, SMC cards, supplements and TA cards can be downloaded as PDFs. There are also eLearning modules and webinars available to view.


Disclaimer: Information intended for healthcare professionals only



Cardiovascular  
 
Ramipril 2.5 mg/5 ml oral solution
Formulary decision guide
April 2014
Commissioned by Rosemont Pharmaceuticals Ltd.


 
 
Warfarin sodium 1 mg/1 ml oral suspension
Formulary decision guide
April 2014
Commissioned by Rosemont Pharmaceuticals Ltd.


 
 
Simvastatin 20 mg/5ml and 40mg/5ml oral suspension
Formulary decision guide
July 2015
Commissioned by Rosemont Pharmaceuticals Ltd.


 
 
Amlodipine 1 mg/ml and 2 mg/ml oral solution
Formulary decision guide
July 2015
Commissioned by Rosemont Pharmaceuticals Ltd.


 
 
Guidance on the management of patients who are prescribed warfarin
Algorithm
September 2015
Funded by Roche Diagnostics Ltd.


 
 
Implementing the NICE quality standard for atrial fibrillation
Checklist
December 2015
Funded by Roche Diagnostics Ltd.


 
 
Improving INR Control and Patient Satisfaction in Primary Care
Other
March 2016
Provided by Roche Diagnostics Ltd


 
 
Central Nervous System  
 
Gabapentin 50 mg/ml oral solution
Formulary decision guide
April 2014
Commissioned by Rosemont Pharmaceuticals Ltd.


 
 
The importance of physical health in schizophrenia and the potential role of lurasidone▼
Supplement
June 2016
Commissioned by Sunovion Pharmaceuticals Europe Ltd.


 
 
Formulary decision guide: Perizam™ (clobazam) 1 mg/ml and 2 mg/ml oral suspension
Formulary decision guide
January 2017
Commissioned by Rosemont Pharmaceuticals Ltd.


 
 
Formulary decision guide: Onexila™ XL (oxycodone hydrochloride) tablets
Formulary decision guide
April 2017
Commissioned by Aspire Pharma.


 
 
Formulary decision guide: Reltebon® prolonged-release tablets (oxycodone hydrochloride)
Formulary decision guide
April 2017
Commissioned by Accord.


 
 
eLearning module  
 
Maintaining high-quality anticoagulation and the use of self-monitoring
eLearning module
July 2015
This eLearning module has been funded by Roche Diagnostics Ltd and developed in partnership with Guidelines.co.uk.


 
 
Formulary decision guide: Fiasp® ▼ (insulin aspart)
Formulary decision guide
May 2017
Commissioned by Novo Nordisk.


Eye, Ear, Nose & Throat  
 
Guideline for the identification and management of swallowing difficulties in adults with learning disability
Working party guideline
February 2014
The development of this working party guideline has been supported by a grant from Rosemont Pharmaceuticals Ltd.


 
 
Dexamethasone 2 mg/5 ml oral solution (Dexsol®)
Formulary decision guide
April 2014
Commissioned by Rosemont Pharmaceuticals Ltd.


 
 
Guideline on the medication management of adults with swallowing difficulties
Working party guideline
September 2015
The development of this working party guideline has been supported by a grant from Rosemont Pharmaceuticals Ltd


 
 
Swallowing Difficulties Protocol: Achieving Best Practice in Medication Administration
Other
February 2016
Supplied by Rosemont Pharmaceuticals Ltd


Gastrointestinal  
 
Implementing the NICE quality standard for constipation in children and young people
Checklist
May 2016
Funded by Norgine Pharmaceuticals Limited.


 
 
Best practice guidance on the managed introduction of biosimilar infliximab within the NHS
Supplement
June 2016
Funded by Napp Pharmaceuticals Limited.


 
 
Management of hepatic encephalopathy in primary care
Algorithm
November 2016
Commissioned by Norgine Pharmaceuticals Limited.


 
 
Management of overt hepatic encephalopathy: a focus on rifaximin-α and NICE TA337
Supplement
December 2016
This Guidelines supplement has been commissioned by Norgine Pharmaceuticals Limited. See inside front cover for full disclaimer. Prescribing information can be found on the outside back cover.


 
 
Budesonide 9 mg prolonged release tablet (Cortiment®) SMC No. (1093/15)
SMC card
January 2017
Commissioned by Ferring Pharmaceuticals Ltd


General  
 
Making medicines safer for children—guidance for the use of unlicensed medicines in paediatric patients
Working party guideline
May 2016
The development of this working party guideline has been supported by a grant from Rosemont Pharmaceuticals Ltd.


 
 
Implementing the consensus guidelines on the medication management of adults with swallowing difficulties
Checklist
February 2013
The production and printing of this checklist has been funded by Rosemont Pharmaceuticals


 
 
Implementing improvements in smoking cessation at a practice level
Supplement
October 2016
Commissioned by Johnson & Johnson Limited.


 
 
e-tiquette
Other
March 2017
With thanks to all those who have contributed to this document, and to Bedfordshire CCG for allowing it to be hosted online at GuidelinesinPractice.co.uk.


 
 
Supporting local implementation of NICE Technology Appraisal 325 on reducing alcohol consumption in adults with alcohol dependence
Supplement
April 2017
Lundbeck Ltd has contributed funding support for this project.


Guidance update eLearning module  
 
NICE asthma quality standard
Guidance update eLearning module
May 2014
This Guidance Update will be of use to all primary healthcare professionals who see patients with asthma.


 
 
Managing adult asthma in primary care—implementing the updated BTS/SIGN guideline
Guidance update eLearning module
This Guidance Update module, which features case study examples, will outline the key updates from 2016 to the British Thoracic Society and Scottish Intercollegiate Guidelines Network British guideline on the management of asthma


Musculoskeletal & Joints  
 
Alendronic acid 70 mg/100 ml oral solution
Formulary decision guide
August 2016
Commissioned by Rosemont Pharmaceuticals Ltd.


 
 
Methotrexate 2 mg/ml oral solution
Formulary decision guide
November 2015
Commissioned by Rosemont Pharmaceuticals Ltd.


Nutrition  
 
Formulary decision guide: Desunin® 800 IU and 4000 IU tablets (colecalciferol 800 IU and 4000 IU [vitamin D3])
Formulary decision guide
August 2016
Commissioned by Meda Pharmaceuticals Ltd.


Product update eLearning module  
 
Qvar® Easi-Breathe®
Product update eLearning module
April 2016
Click here to view a Product Update presentation on Qvar® Easi-Breathe®


Respiratory  
 
 
 
Practical considerations when stepping down treatment in asthma: a round-table discussion
Round-table discussion
June 2016
Commissioned by Napp Pharmaceuticals Limited.


 
 
Formulary decision guide: Qvar® (HFA beclometasone dipropionate)
Formulary decision guide
August 2016
Commissioned by Teva UK Limited.


 
 
 
 
The impact and outcomes of a COPD model care pathway
Guidance Update supplement
November 2016
Commissioned by Astra Zeneca


 
 
Formulary decision guide: Braltus® (tiotropium bromide) inhalation powder
Formulary decision guide
February 2017
Commissioned by Teva UK Limited.


 
 
Formulary decision guide: Aerivio® Spiromax® (salmeterol and fluticasone) dry powder inhaler
Formulary decision guide
March 2017
Commissioned by Teva UK Limited.


 
 
BTS/SIGN 2016 update to British guideline on the management of asthma
Video
November 2016

The British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN) published the latest version of their guideline on the management of asthma in November 2016.1 In this short video, Professor Hilary Pinnock (GP and member of the BTS/SIGN guideline executive group) answers the following questions:



 
 
Implementing the Primary Care Dermatology Society rosacea treatment pathway
Checklist
December 2016
Funded by Galderma UK Ltd.